Clark A, Tate B, Urban B, Schroeder R, Gennuso S, Ahmadzadeh S, McGregor D, Girma B, Shekoohi S, Kaye AD. Bupropion-mediated effects on depression, attention deficit hyperactivity disorder, and smoking cessation. Health Psychol Res. 2023;1(11):81043. https://doi.org/10.52965/001c.81043.
Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Primary Care Companion J Clin Psychiatry. 2004;6(4):159–66. https://doi.org/10.4088/pcc.v06n0403.
Article PubMed PubMed Central Google Scholar
Connarn JN, Zhang X, Babiskin A, Sun D. Metabolism of bupropion by carbonyl reductases in liver and intestine. Drug Metab Dispos. 2015Jul;43(7):1019–27. https://doi.org/10.1124/dmd.115.063107.
Article PubMed PubMed Central CAS Google Scholar
Sager JE, Price LS, Isoherranen N. Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro. Drug Metab Dispos. 2016Oct;44(10):1709–19. https://doi.org/10.1124/dmd.116.072363.
Article PubMed PubMed Central CAS Google Scholar
Kanu SS, Ojha A, Ramajayam R, Bhargava S, Bhavna,. An updated review on translabial mucosa: a significant area to design and deliver a drug. J Pharm Sci Res. 2020;12(11):1425–30.
Varshosaz J, Zaki MR, Minaiyan M, Banoozadeh J. Preparation, Optimization, and Screening of the Effect of Processing Variables on Agar Nanospheres Loaded with Bupropion HCl by a D-Optimal Design. Biomed Res Int. 2015;1: 571816. https://doi.org/10.1155/2015/571816.
Swarnalatha N, Vidyavathi M, Rani JS. Design, characterization, and optimization of solid lipid nanoparticles of bupropion by using a 23 factorial design. Pharm Chem J. 2023;57:590–602. https://doi.org/10.1007/s11094-023-02924-y.
Harini K, Alomar SY, Vajagathali M, Manohar Das S, Thirumalai A, Giri Goswami K, Giri Goswami A. Niosomal bupropion. Exploring therapeutic frontiers through behavioral profiling. Pharmaceuticals (Basel). 2024;17(3):366. https://doi.org/10.3390/ph17030366.
Article PubMed CAS Google Scholar
Muralidhar P, Bhargav E, Srinath B. Formulation and optimization of bupropion HCL microsponges by 23 factorial design. Int J Pharm Sci Res. 2017;8(3):1134–44. https://doi.org/10.13040/IJPSR.0975-8232.8(3).1134-44.
Madhav NS, Yadav AP. A novel translabial platform utilizing bioexcipients from Litchi chinensis for the delivery of rosiglitazone maleate. Acta Pharmaceutica Sinica B. 2013;3(6):408–15. https://doi.org/10.1016/j.apsb.2013.10.004.
Dede R, Kasabe A, Bhosale A, Gupta H, Bhalerao A, Chorage T. Formulation and Evaluation of Medicated Lipstick Using Pioglitazone. Int J Pharm Res Applic. 2021;6(5):693–6. https://doi.org/10.35629/7781-0605693696.
Madhav N, Yadav A. Development and evaluation of novel repaglinide biostrips for translabial delivery. Int Res J Pharm. 2013;4(5):198–202. https://doi.org/10.7897/2230-8407.04540.
Tiwari G, Tiwari R, Kaur A. Pharmaceutical Considerations of Translabial Formulations for Treatment of Parkinson’s Disease: A Concept of Drug Delivery for Unconscious Patients. Curr Drug Deliv. 2023;20(8):163–75. https://doi.org/10.2174/1567201819666220516161413.
Shaker DS, Ishak RA, Ghoneim A, Elhuoni MA. Nanoemulsion: A review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs. Sci Pharm. 2019;87(3):17. https://doi.org/10.3390/scipharm87030017.
Acharya SD, Tamane PK, Khante SN, Pokharkar VB. QbD-based optimization of curcumin nanoemulsion: DoE and cytotoxicity studies. Indian J Pharm Educ Res. 2020;54(2):329–36. https://doi.org/10.5530/ijper.54.2.38.
Savale SK. Quality by design (QbD) approach used in development of pharmaceutical formulations. Asian J Biomater Res. 2017;3(6):11–24.
Cunha S, Costa CP, Moreira JN, Lobo JM, Silva AC. Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review. Nanomedicine. 2020Aug;1(28): 102206. https://doi.org/10.1016/j.nano.2020.102206.
Waghule T, Dabholkar N, Gorantla S, Rapalli VK, Saha RN, Singhvi G. Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk-based industrial approach. Biomed Pharmacother. 2021Sep;1(141): 111940. https://doi.org/10.1016/j.biopha.2021.111940.
Zen N.I.M., Gani S.S.A., Shamsudin R., Masoumi H.R.F., The use of D-optimal mixture design in optimizing development of Okara tablet formulation as a dietary supplement. Sci World J. 2015:684319. https://doi.org/10.1155/2015/684319.
Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49(1):57–71. https://doi.org/10.1146/annurev.pharmtox.48.113006.094742.
Article PubMed PubMed Central CAS Google Scholar
Nagano T, Katsurada M, Yasuda Y, Kobayashi K, Nishimura Y. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials. Ther Adv Respir Dis. 2019;13:1753466619875925. https://doi.org/10.1177/1753466619875925.
Article PubMed PubMed Central Google Scholar
Lou D, Chang X, Li W, Zhao Q, Wang Y, Zhou Z. Paraquat affects the homeostasis of the dopaminergic system in PC12 cells. Pestic Biochem Physiol. 2012;103(2):81–6. https://doi.org/10.1016/j.pestbp.2012.04.001.
Namini MS, Beheshtizadeh N, Ebrahimi-Barough S, Ai J. Human endometrial stem cell-derived small extracellular vesicles enhance neurite outgrowth and peripheral nerve regeneration through activating the PI3K/AKT signaling pathway. J Transl Med. 2025;23(1):6. https://doi.org/10.1186/s12967-024-06048-z.
Article PubMed PubMed Central CAS Google Scholar
Meerloo JV, Kaspers GJL, Cloos J. Cell sensitivity assays: the MTT assay. Methods Mol Biol. 2011;731:237–45. https://doi.org/10.1007/978-1-61779-080-5_20.
Article PubMed CAS Google Scholar
Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT, and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett. 2006Jan 5;160(2):171–7. https://doi.org/10.1016/j.toxlet.2005.07.001.
Article PubMed CAS Google Scholar
Ahmad U, Akhtar J, Singh SP, Badruddeen, Ahmad FJ, Siddiqui S, Wahaj U. Silymarin Nanoemulsion against Human Hepatocellular Carcinoma: Development and Optimization. Artif Cells Nanomed Biotechnol. 2018;46(2):231–41. https://doi.org/10.1080/21691401.2017.1324465.
Article PubMed CAS Google Scholar
Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, Talegaonkar S. Nanoemulsion components screening and selection: a technical note. AAPS Pharm SciTech. 2009;10(1):69–76. https://doi.org/10.1208/s12249-008-9178-x.
Dhawan S, Nanda S. Implementation of the Quality by Design (QbD) concept for the development of emulsion-based nano-tailored gel for improved anti-photoaging potential of silymarin. J Drug Deliv Sci Technol. 2023Mar;1(81): 104201. https://doi.org/10.1016/j.jddst.2023.104201.
Akhtar J, Siddiqui HH, Fareed S, Khalid BM, Aqil M. Nanoemulsion: for improved oral delivery of repaglinide. Drug Deliv. 2016;23(6):2026–34. https://doi.org/10.3109/10717544.2015.1077290.
Article PubMed CAS Google Scholar
ICH, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Pharmaceutical Development Q8 (R2), ICH Harmon. Tripart. Guidel, 2009. https://www.ema.europa.eu/en/ich-q8-r2-pharmaceutical-development-scientific-guideline
Thakur K, Mahajan A, Sharma G, Singh B, Raza K, Chhibber S, Katare OP. Implementation of the Quality by Design (QbD) approach in the development of silver sulfadiazine-loaded egg oil organogel: an improved dermatokinetic profile and therapeutic efficacy in burn wounds. Int J Pharm. 2020;576: 118977. https://doi.org/10.1016/j.ijpharm.2019.118977.
Article PubMed CAS Google Scholar
Shakeel F, Ramadan W. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids Surf B Biointerfaces. 2010;75(1):356–62. https://doi.org/10.1016/j.colsurfb.2009.09.010.
Comments (0)